Stockscreener 앱 받기
25.70
0.33%
0.085
시간 외 거래:
25.45
-0.25
-0.97%
Castle Biosciences Inc 주식(CSTL)의 최신 뉴스
Maetzold, Castle Biosciences CEO, sells $500k in CSTL stock - Investing.com
Derek Maetzold Sells 650 Shares of Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells 18,650 Shares of Stock - MarketBeat
Castle Biosciences (CSTL) CEO sells 19,300 shares under 10b5-1 plan - Stock Titan
Castle Biosciences introduces 487-gene panel to guide JAK inhibitor or Th2 therapy decisions - Traders Union
Castle Biosciences (CSTL) loses 16.8% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Risk Recap: What’s Castle Biosciences Inc.’s historical returnGold Moves & Growth Focused Entry Point Reports - baoquankhu1.vn
Castle Biosciences (NASDAQ: CSTL) CEO sells 30,779 shares under 10b5-1 plan - Stock Titan
Big Picture: What is the implied volatility of Castle Biosciences IncQuarterly Trade Report & Long-Term Safe Return Strategies - baoquankhu1.vn
Castle Biosciences (NASDAQ:CSTL) Insider Sells $526,582.12 in Stock - MarketBeat
Castle Biosciences Officer Sells Shares - TradingView
Castle Biosciences (NASDAQ: CSTL) CCO sells 20,863 pre-planned shares - Stock Titan
Castle Biosciences (CSTL) Study Validates DecisionDx-Melanoma Te - GuruFocus
Castle Biosciences (CSTL) CEO sells 44,125 shares under 10b5-1 plan - Stock Titan
Prospective, Multi-center Study Published in Future - GlobeNewswire
New melanoma test flags patients who can skip lymph node biopsy - Stock Titan
CSTL (NASDAQ: CSTL) Form 144 shows proposed resale of 20,863 shares - Stock Titan
Derek Maetzold sells shares; CSTL (NASDAQ: CSTL) Form 144 lists large late‑2025 trades - Stock Titan
Stokes Frank sells Castle Biosciences (CSTL) stock worth $192k - Investing.com Nigeria
Castle Biosciences Inc (CSTL) CFO Frank Stokes Sells 6,001 Shares - GuruFocus
Insider Selling: Castle Biosciences (NASDAQ:CSTL) CFO Sells 6,001 Shares of Stock - MarketBeat
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Director Sells 7,403 Shares of Stock - MarketBeat
Castle Biosciences (CSTL) CFO sells 6,001 shares under 10b5-1 plan - Stock Titan
Castle Biosciences (CSTL) director exercises options and sells shares - Stock Titan
DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest - GlobeNewswire
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2025 earnings call transcript - MSN
Aug Wrap: Whats next for Castle Biosciences Inc stockVolume Spike & Expert Verified Movement Alerts - baoquankhu1.vn
Death Cross: Will Castle Biosciences Inc benefit from current market trendsEarnings Growth Summary & Low Volatility Stock Suggestions - baoquankhu1.vn
Castle Biosciences, Inc. (CSTL) expected to beat earnings estimates: What to know ahead of Q4 release - MSN
How Castle Biosciences (CSTL) Story Is Shifting With New Revenue Targets And Fair Value - Yahoo Finance
Stokes Frank sells Castle Biosciences (CSTL) stock worth $192k By Investing.com - Investing.com India
Frank Stokes Sells 7,000 Shares of Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
Castle Biosciences (CSTL) CCO logs RSU grant, conversions and tax share withholdings - Stock Titan
Castle Biosciences (CSTL) CEO details RSU grants, conversions and tax share disposals - Stock Titan
Castle Biosciences: Interview With Founder, CEO, And President Derek Maetzold About The Molecular Diagnostics Company - Pulse 2.0
Castle Biosciences Stock Hits Day Low of $27.22 Amid Price Pressure - Markets Mojo
Proposed 4,748-share option exercise sale (CSTL) - Stock Titan
Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma’s i31-SLNB, Identifying T1b-T2a Melanoma Patients Who May Safely Avoid SLNB - The Manila Times
Melanoma test may let some patients skip lymph node surgery - Stock Titan
Castle Biosciences (NASDAQ:CSTL) Lowered to Hold Rating by Zacks Research - MarketBeat
Castle Biosciences to Present Data at SSO 2026 on DecisionDx-Melanoma's i31-SLNB, Identifying T1b-T2a Melanoma Patients Who May Safely Avoid SLNB - Bitget
Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas - Bitget
Morgan Stanley lists 7,000 CSTL RSU shares for sale (CSTL) - Stock Titan
CSTL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Medical test company opens 23-acre HQ with trails, gym and food truck pad - Stock Titan
Canaccord reiterates Castle Biosciences stock rating on Q4 beat By Investing.com - Investing.com India
Canaccord reiterates Castle Biosciences stock rating on Q4 beat - Investing.com Nigeria
Aug Volume: What is the target price for Seer Inc stockEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn
Q4 2025 Castle Biosciences Inc Earnings Call Transcript - GuruFocus
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2025 Earnings Call Transcript - Insider Monkey
Castle Biosciences (CSTL) Receives a Buy from Lake Street - The Globe and Mail
Castle Biosciences, Inc. (CSTL) Stock Analysis: Unveiling a Promising 50.96% Upside for Investors - DirectorsTalk Interviews
Castle Biosciences (NASDAQ:CSTL) Shares Gap DownWhat's Next? - MarketBeat
Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down - Finviz
Castle Biosciences (CSTL) Analyst Rating Update: Baird Raises Pr - GuruFocus
Robert W. Baird Forecasts Strong Price Appreciation for Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
Expert Outlook: Castle Biosciences Through The Eyes Of 6 Analysts - Benzinga
Castle Biosciences, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:CSTL) 2026-02-27 - Seeking Alpha
0.55%
2.50%
자본화:
|
볼륨(24시간):